drugset / Trial / NCT00703885

PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

NCT00703885

RandomizedCrossoverSingle-blindDiagnostic

Summary

The purpose of this study is to use functional magnetic resonance imaging (fMRI) in healthy controls to examine the acute effects of certain anxiolytic medications on brain function.

Timeline

Start
2008-01
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprazolam Small molecule 0.25 mg Oral
Comparator Alprazolam Small molecule 1 mg Oral

Indications